Your browser doesn't support javascript.
loading
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial.
Mathieu, Chantal; Rudofsky, Gottfried; Phillip, Moshe; Araki, Eiichi; Lind, Marcus; Arya, Niki; Thorén, Fredrik; Scheerer, Markus F; Iqbal, Nayyar; Dandona, Paresh.
Afiliação
  • Mathieu C; Clinical and Experimental Endocrinology, University of Leuven, Leuven, Belgium.
  • Rudofsky G; Endocrinology and Metabolic Diseases, Cantonal Hospital Olten, Olten, Switzerland.
  • Phillip M; Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Tel-Aviv University, Tel-Aviv, Israel.
  • Araki E; Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan.
  • Lind M; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Arya N; Department of Medicine, NU-Hospital Group, Uddevalla, Sweden.
  • Thorén F; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Scheerer MF; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Iqbal N; BioPharmaceuticals Medical, AstraZeneca, Wedel, Germany.
  • Dandona P; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
Diabetes Obes Metab ; 22(9): 1516-1526, 2020 09.
Article em En | MEDLINE | ID: mdl-32311204
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article